Preclinical evaluation of rBCG-h12: an engineered Bacillus Calmette-Guérin with an enhanced activity against bladder and pancreatic cancers. - Yeh CC; Fan CS; Chen LL; Chua KV; Hsu CH; Chen CC; Tan ZL; Tsai PC; Song YD; Low YS; Yang SJ; Chen YY; et al. (Cancer immunology, immunotherapy : CII, 2026)